好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Virtual Fall Conference | C18 - Neurology Update 5: Multiple Sclerosis

Saturday 11/07/20
11:05 AM - 11:35 AM CST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Stephen Krieger, MD, FAAN
General Neurology, Multiple Sclerosis
Participants should be familiar with recent advances in the diagnosis of MS and make rational choices from the increasing therapeutic options now available.
0.50 CME credit
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Intermediate
Fellow, Resident, General Neurologist, Advanced Practice Provider
Didactic

Program Materials

Event Timeline
11:05 AM - 11:25 PM CST Speaker Multiple Sclerosis
Stephen Krieger, MD, FAAN
11:25 AM - 11:35 AM CST Q&A Live Q&A
Stephen Krieger, MD, FAAN
Faculty Disclosures
Stephen Krieger, MD, FAAN Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expert Witness. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen.